Debulking With Rotational Atherectomy Versus Balloon Angioplasty In Patients With In-stent Restenosis
- Conditions
- Coronary Vessels
- Interventions
- Procedure: Balloon angioplastyProcedure: Rotational atherectomy followed by balloon angioplasty
- Registration Number
- NCT03401203
- Lead Sponsor
- Seung-Jung Park
- Brief Summary
This study is to establish the primary hypothesis that debulking with rotational atherectomy (RA) followed by balloon angioplasty (BA) is superior to BA alone for lesion preparation in patients with coronary in-stent restenosis (ISR) regarding angiography-measured in-segment minimal lumen area at 1 year.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 95
- Men or women at least 19 years of age
- Subjects with coronary In-stent restenosis planned revascularization
- In-stent restenosis with neointimal hyperplasia evaluated by intravascular imaging
- The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethical Committee of the respective clinical site.
- Complex lesion anatomy that disables rotational atherectomy
- Any clinically significant abnormality identified at the screening visit, physical examination, laboratory tests, or electrocardiogram which, in the judgment of the Investigator, would preclude safe completion of the study.
- Life expectancy < 1 years for any non-cardiac or cardiac causes
- Unwillingness or inability to comply with the procedures described in this protocol.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description balloon angioplasty Balloon angioplasty - rotational atherectomy followed by balloon angioplasty Rotational atherectomy followed by balloon angioplasty -
- Primary Outcome Measures
Name Time Method In-segment minimal lumen diameter on angiographic 1 year
- Secondary Outcome Measures
Name Time Method Angiographic outcomes immediate after procedure 1 hour In-segment and in-stent minimal lumen diameter and diameter stenosis
Device success rate 1 year OCT outcomes immediate after procedure : In-segment and in-stent minimal lumen area 1 hour OCT outcomes immediate after procedure : In-segment and in-stent neointimal volume 1 hour Angiographic outcomes : In-segment and in-stent late loss, diameter stenosis 1 year OCT outcomes : in-segment and in-stent late lumen area, minimal lumen area loss 1 year composite event rate 1 year A composite event of following factors is defined as the occurrence of any event from these events and denoted that event as the union of these.
* Death (cardiac, vascular, non-cardiovascular)
* Myocardial infarction (periprocedural, spontaneous)
* Stent thrombosis (definite/probable)
* Stroke
* Any revascularization
* Target lesion revascularization (TLR)
* Target vessel revascularization (TVR)
* Clinically significant bleeding (BARC type 2,3,4,5)
* Target lesion failure (cardiac death, target vessel MI or ischemia-driven TLR)
* Target vessel failure (cardiac death, target vessel MI or ischemia-driven TVR)
* A composite of all-cause death, MI, any repeat revascularization
* A composite of cardiac death, target vessel MI, stroke, or clinically significant bleeding (Bleeding Academic Research Consortium (BARC) type 2,3,4,5)
Trial Locations
- Locations (3)
Chonnam National University Hospital
🇰🇷Gwangju, Korea, Republic of
Asan Medical Center
🇰🇷Seoul, Korea, Republic of
Soon Chun Hyang University Hospital Bucheon
🇰🇷Bucheon, Korea, Republic of